Compounds > ondansetron
Page last updated: 2024-11-01

ondansetron and Hypermelanosis

ondansetron has been researched along with Hypermelanosis in 1 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iglesias, ME1
España, A1
Redondo, P1
Quintanilla, E1

Other Studies

1 other study available for ondansetron and Hypermelanosis

ArticleYear
Fixed drug eruption secondary to ondansetron.
    Dermatology (Basel, Switzerland), 1995, Volume: 191, Issue:3

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Eruptio

1995